Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Ju Fu Tang Biotech Holdings Co's annualizedNet Income for the quarter that ended in Mar. 2026 was HK$3.76 Mil.
Ju Fu Tang Biotech Holdings Co's average Total Assets over the quarter that ended in Mar. 2026 was HK$95.79 Mil. Therefore, Ju Fu Tang Biotech Holdings Co's annualized ROA % for the quarter that ended in Mar. 2026 was 3.92%.
The historical rank and industry rank for Ju Fu Tang Biotech Holdings Co's ROA % or its related term are showing as below:
HKSE:08217'
s ROA % Range Over the Past 10 Years
Min: -23.24 Med: -7.12 Max: 26.96
Current: 25.72
During the past 13 years, Ju Fu Tang Biotech Holdings Co's highest ROA % was 26.96%. The lowest was -23.24%. And the median was -7.12%.
HKSE:08217's ROA % is ranked better than 99.27% of 1786
companies
in the Construction industry
Industry Median: 2.865
vs HKSE:08217: 25.72
Ju Fu Tang Biotech Holdings Co (HKSE:08217) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is two times the semi-annual (Mar. 2026) net income data. The Revenue data used here is two times the semi-annual (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Ju Fu Tang Biotech Holdings Co ROA % Related Terms
Ju Fu Tang Biotech Holdings Co ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Engineering & Construction subindustry, Ju Fu Tang Biotech Holdings Co's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ju Fu Tang Biotech Holdings Co ROA % vs Construction Industry
For the Construction industry and Industrials sector, Ju Fu Tang Biotech Holdings Co's ROA % distribution charts can be found below:
* The bar in red indicates where Ju Fu Tang Biotech Holdings Co's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is two times the semi-annual (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Ju Fu Tang Biotech Holdings Co (HKSE:08217) has a ROA % of 3.92% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. According to the industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #13 out of 1786 companies in the Construction industry, placing it in the top 0.7%.
Is Ju Fu Tang Biotech Holdings Co's ROA % too high?
Ju Fu Tang Biotech Holdings Co's current ROA % is 3.92%. The Construction industry median ROA % is 2.87. Ju Fu Tang Biotech Holdings Co's value of 3.92% is 36.8% above this industry median. Based on the distribution chart, Ju Fu Tang Biotech Holdings Co ranks #13 out of 1786 companies in the Construction industry, which is in the top quartile — a strong position relative to peers. Overall, Ju Fu Tang Biotech Holdings Co has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ju Fu Tang Biotech Holdings Co's ROA % compare to PWR and FIX?
According to the Construction industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #13 out of 1786 companies for ROA %. This places Ju Fu Tang Biotech Holdings Co in the top 1% of its industry — outperforming the majority of peers. The industry median ROA % is 2.87. Ju Fu Tang Biotech Holdings Co's value of 3.92% is 36.8% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Construction company?
The median ROA % among Construction companies is 2.87, based on 1,786 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ju Fu Tang Biotech Holdings Co's current ROA % of 3.92% is 36.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. For the Construction industry, the median ROA % is 2.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ju Fu Tang Biotech Holdings Co's current ROA % is 3.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ju Fu Tang Biotech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co (HKSE:08217) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.11 — trading 28.7% below its estimated fair value. The current ROA % is 3.92% and 36.8% above the Construction industry median of 2.87. Ju Fu Tang Biotech Holdings Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Ju Fu Tang Biotech Holdings Co (HKSE:08217), the current ROA % is 3.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ju Fu Tang Biotech Holdings Co (HKSE:08217) Overvalued in 2026?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co stock appears to be undervalued.
The current stock price of HK$0.11 is trading 28.7% below its estimated GF Value™ of HK$0.15.
GuruFocus considers Ju Fu Tang Biotech Holdings Co to be Modestly Undervalued.
Key valuation signals for HKSE:08217:
ROA %: 3.92%
GF Value™: HK$0.15 vs. price of HK$0.11 (28.7% below fair value)
Industry Position: 36.8% above the Construction median (#13 of 1786)
No single metric tells the full story. See the HKSE:08217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ju Fu Tang Biotech Holdings Co Ltd, formerly known as WMHW Holdings Ltd, is an investment holding company operating through its subsidiaries. It engaged in the provision of construction works and investment holding.
36GF Score
Get the complete analysis for HKSE:08217
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08217 has been successfully added to your 
